Biotech

All Articles

Zephyrm seeks Hong Kong IPO to finance phase 3 cell treatment tests

.Zephyrm Bioscience is actually gusting towards the Hong Kong stock market, filing (PDF) for an IPO ...

Frazier Lifestyle Sciences gathers $630M for small, mid-cap biotechs

.Frazier Daily life Sciences has sourced an even further $630 thousand for its own fund focused on t...

GigaGen achieves up to $135M BARDA money to beat botox

.Antibody aficionado GigaGen, a subsidiary of Spanish biopharma Grifols, is increase its tech to tak...

GPCR organization Septerna declare IPO on toughness of preclinical records

.Septerna is about to find out exactly how a biotech without "any type of purposeful professional da...

Kurma finalizes first $154M haul for biggest biotech fund as yet

.European VC organization Kurma Partners has actually introduced its most recent biotech fund, along...

Prothena ensures one director while another places-- Chutes &amp Ladders

.Welcome to today's Chutes &amp Ladders, our summary of substantial management hirings, firings and ...

Editas exploit Tip Cas9 licensing rights for $57M

.Versus the backdrop of a Cas9 license struggle that refuses to pass away, Editas Medicine is cashin...

Ultragenyx changes genetics treatment application to call up effectiveness

.A minority of individuals taking Ultragenyx Pharmaceutical's Wilson ailment gene treatment UX701 ha...

Biopharma discharge price supports in Q3: Fierce Biotech review

.As summer warmth looks to cool down winds, hopes that this year would deliver widespread sector all...

J &amp J goes down period 2 dengue prospect in most up-to-date change coming from vaccines

.Johnson &amp Johnson's deprioritization of its own infectious ailment pipe has actually professed a...